Biodesix now carries a higher fair value estimate, with the assessed price target moving from US$34 to US$39, which is about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results